title: CD69+NK cells contribute to the murine hepatitis virus strain 3-induced murine hepatitis.
abstract: The role of hepatic CD69+ natural killer (NK) cells in virus-induced severe liver injury and subsequent hepatic failure is not well defined. In this study, a mouse model of fulminant liver failure (FHF) induced by murine hepatitis virus strain 3 (MHV-3) was used to study the role of hepatic CD69+NK cells in the development of FHF. The CD69 expression in NK cells in the liver, spleen, bone marrow and peripheral blood was detected by using flow cytometry. The correlation between the CD69 level in hepatic NK cells and liver injury was studied. The functional marker (CD107a), and activating and inhibitory receptor (NKG2D and NKG2A) expressed on CD69+NK cells and CD69-NK cells were detected by using flow cytometry. Pro-inflammatory cytokines (IL-9, IFN-γ and TNF-α) were also examined by using intracellular staining. After MHV-3 infection, the number of CD69+NK cells in the liver of BALB/cJ mice was increased markedly and peaked at 72 h post-infection. Similar changes were also observed in the spleen, bone marrow and peripheral blood. Meanwhile, the CD69 expression in hepatic NK cells was highly correlated with the serum level of ALT and AST. The expression of CD107a and NKG2D, as well as the production of TNF-α, IFN-γ and IL-9 in hepatic CD69+NK cells was all significantly up-regulated during 48-72 h post-infection. In contrast, the NKG2A expression was increased in hepatic CD69-NK cells but not in CD69+NK cells. These results suggested that hepatic CD69+NK cells play a pivotal role in the pathogenesis of FHF by enhancing degranulation and cytotoxic ability of NK cells and increasing the production of pro-inflammatory cytokines.
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Ding
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors.forename: Tao
authors.initials: T
authors.lastname: Chen
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors.forename: Xiao-Jing
authors.initials: XJ
authors.lastname: Wang
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors.forename: Li
authors.initials: L
authors.lastname: Zhou
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors.forename: Ai-Chao
authors.initials: AC
authors.lastname: Shi
authors.affiliation: Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. qning@tjh.tjmu.edu.cn.
authors.forename: Qin
authors.initials: Q
authors.lastname: Ning
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D018352:Coronavirus Infections / Q000276:immunology*; D005260:Female; D006524:Hepatitis, Viral, Animal / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology*; D037181:Lectins, C-Type / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D006517:Murine hepatitis virus / Q000276:immunology*; D000099192:CD69 Antigens
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D037181:Lectins, C-Type; D000099192:CD69 Antigens
references.citation: Semin Liver Dis. 2003 Aug;23(3):217-26
references.pmid: 14523675
references.citation: Curr Gastroenterol Rep. 2003 Feb;5(1):39-47
references.pmid: 12530947
references.citation: J Exp Med. 2007 Mar 19;204(3):667-80
references.pmid: 17353365
references.citation: J Clin Invest. 2003 Jul;112(1):58-66
references.pmid: 12840059
references.citation: Annu Rev Immunol. 1999;17:189-220
references.pmid: 10358757
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1915-9
references.pmid: 19181844
references.citation: Hum Immunol. 2010 Jan;71(1):29-35
references.pmid: 19782712
references.citation: Viral Immunol. 2012 Feb;25(1):21-8
references.pmid: 22233255
references.citation: J Immunol. 2005 Dec 1;175(11):7466-73
references.pmid: 16301654
references.citation: J Immunol Methods. 2004 Nov;294(1-2):15-22
references.pmid: 15604012
references.citation: J Exp Med. 1993 Aug 1;178(2):537-47
references.pmid: 8340758
references.citation: Biochim Biophys Acta. 2002 Nov 11;1592(3):345-58
references.pmid: 12421677
references.citation: J Immunol Methods. 2011 Sep 30;372(1-2):187-95
references.pmid: 21839083
references.citation: Nat Immunol. 2002 Jun;3(6):523-8
references.pmid: 12006976
references.citation: J Exp Med. 2005 Oct 3;202(7):1001-12
references.pmid: 16203869
references.citation: Nat Immunol. 2006 Nov;7(11):1217-24
references.pmid: 17013389
references.citation: Proc Natl Acad Sci U S A. 1999 May 25;96(11):6336-40
references.pmid: 10339588
references.citation: Blood. 2006 Jan 1;107(1):159-66
references.pmid: 16150947
references.citation: Cell Immunol. 2009;254(2):149-54
references.pmid: 18835598
references.citation: J Immunol Methods. 2003 Oct 1;281(1-2):65-78
references.pmid: 14580882
references.citation: Eur J Immunol. 1993 Jul;23(7):1643-8
references.pmid: 8100776
references.citation: Nat Rev Immunol. 2008 Apr;8(4):259-68
references.pmid: 18340344
references.citation: Leukemia. 2005 Oct;19(10):1849-51; author reply 1857
references.pmid: 16079888
references.citation: J Immunol. 2012 Feb 15;188(4):2001-13
references.pmid: 22250092
references.citation: J Immunol. 2007 Apr 15;178(8):4764-70
references.pmid: 17404256
references.citation: Eur J Immunol. 2003 May;33(5):1235-41
references.pmid: 12731048
references.citation: J Virol. 2000 Feb;74(4):1648-57
references.pmid: 10644334
references.citation: Annu Rev Immunol. 2001;19:65-91
references.pmid: 11244031
references.citation: J Immunol. 2010 Jan 1;184(1):466-75
references.pmid: 19949088
references.citation: Blood. 2005 Mar 1;105(5):2082-9
references.pmid: 15536146
references.citation: J Immunol. 2006 Feb 1;176(3):1517-24
references.pmid: 16424180
references.citation: Immunology. 2007 Oct;122(2):291-301
references.pmid: 17521371
references.citation: J Immunol. 1998 Apr 1;160(7):3487-93
references.pmid: 9531310
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12445-50
references.pmid: 8901601